Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - TOTAL CURRENT LIABILITIES
Total Current Liabilities DNLI - Denali Therapeutics Inc.
78 M
LAST VALUE
-54.59%
2 YEAR CAGR
18.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR